Abiopharma

🔍 TENG CHIN-CHI (Executive)

Company: CADENCE DESIGN SYSTEMS INC (CDNS)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 39,032 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 148,463.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,364 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 155,827.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,546 shares of Common Stock at $289.64 per share (Direct)
  Date: 2026-03-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 152,281.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents Performance-Based Restricted Stock Units that have met the performance criteria.
• F2: Represents Performance-Based Restricted Stock Units that have met the performance criteria, which vest in three equal annual installments on the first, second and third anniversaries of the grant date subject to continued service.
• F3: Shares withheld to satisfy tax obligations arising out of vesting of Performance-Based Restricted Stock Units that have met the performance criteria.